Cycloserine
Cycloserine Capsules, USP, 250 mg, Blister Pack × 30
Approved
Approval ID
0071f9f3-a29b-4ba6-9555-69f672501cbc
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 19, 2023
Manufacturers
FDA
Parsolex Gmp Center, Inc.
DUNS: 159802532
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cycloserine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code13845-1202
Application NumberANDA060593
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cycloserine
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 19, 2023
FDA Product Classification
INGREDIENTS (1)
CYCLOSERINEActive
Quantity: 250 mg in 1 1
Code: 95IK5KI84Z
Classification: ACTIB